PMID- 38353680 OWN - NLM STAT- Publisher LR - 20240214 IS - 1861-0692 (Electronic) IS - 1861-0684 (Linking) DP - 2024 Feb 14 TI - Valve unit instead of intensive or intermediate care unit admission following transcatheter edge-to-edge mitral valve repair is safe and reduces postprocedural complications. LID - 10.1007/s00392-024-02384-8 [doi] AB - BACKGROUND: Transcatheter edge-to-edge mitral valve repair (M-TEER) is often performed in general anesthesia, and postprocedural monitoring is usually warranted on an intensive or intermediate care unit (ICU/IMC). We evaluated the implications of a dedicated valve unit (VU) instead of an ICU/IMC for monitoring after M-TEER. METHODS AND RESULTS: In total, 624 patients were retrospectively analyzed. A total of 312 patients were primarily transferred to either ICU or IMC following M-TEER, and 312 patients were scheduled for the VU in the absence of indications for ICU/IMC treatment. Hospital stay was significantly shorter in VU patients (median 6.0 days (interquartile range (IQR) 5.0 - 8.0) vs. 7.0 days (IQR 6.0 - 10.0), p < 0.001) and their risk for infections (2.9 vs. 7.7%, p = 0.008) and delirium (0.6 vs. 2.6%, p = 0.056) was substantially lower compared to ICU/IMC patients. In-hospital mortality was similar in both groups (0.6% vs. 1.3%, p = 0.41). Fifty patients (16.0%) in the VU group had to cross over to unplanned ICU/IMC admission. The most frequent indication was prolonged need for catecholamines (52.0%). Patients with ICU/IMC crossover had more advanced stages of heart failure (LV-EF < 30% in 36.0 vs. 16.0%, p = 0.001; severe concomitant tricuspid regurgitation in 48.0 vs. 27.8%, p = 0.005) and an LV-EF < 30% was independently associated with unplanned ICU/IMC admission. CONCLUSIONS: Following M-TEER postprocedural monitoring on a VU instead of an ICU/IMC is safe, reduces complications, and spares ICU capacities. Patients with advanced heart failure have a higher risk for unplanned ICU/IMC treatment after M-TEER. CI - (c) 2024. The Author(s). FAU - Groger, Matthias AU - Groger M AD - Department of Internal Medicine II, Ulm University Heart Center, University of Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany. FAU - Felbel, Dominik AU - Felbel D AD - Department of Internal Medicine II, Ulm University Heart Center, University of Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany. FAU - Paukovitsch, Michael AU - Paukovitsch M AD - Department of Internal Medicine II, Ulm University Heart Center, University of Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany. FAU - Schneider, Leonhard Moritz AU - Schneider LM AD - Department of Internal Medicine II, Ulm University Heart Center, University of Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany. FAU - Markovic, Sinisa AU - Markovic S AD - Department of Internal Medicine II, Ulm University Heart Center, University of Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany. FAU - Rottbauer, Wolfgang AU - Rottbauer W AD - Department of Internal Medicine II, Ulm University Heart Center, University of Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany. FAU - Kessler, Mirjam AU - Kessler M AUID- ORCID: 0000-0001-6423-0508 AD - Department of Internal Medicine II, Ulm University Heart Center, University of Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany. mirjam.kessler@uniklinik-ulm.de. LA - eng PT - Journal Article DEP - 20240214 PL - Germany TA - Clin Res Cardiol JT - Clinical research in cardiology : official journal of the German Cardiac Society JID - 101264123 SB - IM OTO - NOTNLM OT - Intensive care OT - Mitral valve repair OT - Postprocedural care OT - TEER EDAT- 2024/02/14 12:50 MHDA- 2024/02/14 12:50 CRDT- 2024/02/14 11:03 PHST- 2023/10/15 00:00 [received] PHST- 2024/01/19 00:00 [accepted] PHST- 2024/02/14 12:50 [medline] PHST- 2024/02/14 12:50 [pubmed] PHST- 2024/02/14 11:03 [entrez] AID - 10.1007/s00392-024-02384-8 [pii] AID - 10.1007/s00392-024-02384-8 [doi] PST - aheadofprint SO - Clin Res Cardiol. 2024 Feb 14. doi: 10.1007/s00392-024-02384-8.